These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 10418738)

  • 21. Risk factors for coronary heart disease and acute-phase proteins. A population-based study.
    Danesh J; Muir J; Wong YK; Ward M; Gallimore JR; Pepys MB
    Eur Heart J; 1999 Jul; 20(13):954-9. PubMed ID: 10361047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Acute-phase response of the body (theoretical aspects and clinical significance)].
    Stefani DV; Shterengarts BP; Toksambaeva SZh
    Pediatriia; 1987; (3):62-8. PubMed ID: 3110731
    [No Abstract]   [Full Text] [Related]  

  • 23. Enhanced inflammatory response to coronary angioplasty in patients with severe unstable angina.
    Simon K; Ory E; Böhm T
    Circulation; 1999 Nov; 100(19):e95. PubMed ID: 10556233
    [No Abstract]   [Full Text] [Related]  

  • 24. [Haemostatic and inflammation markers in acute coronary syndromes and its relationship with adverse cardiovascular events].
    Díaz CJ; Núñez AC; Flores MI; Arcaute HD; Archondo T
    Arch Cardiol Mex; 2006; 76(4):366-75. PubMed ID: 17315612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Establishment of an in-house ELISA and the reference range for serum amyloid A (SAA): complementarity between SAA and C-reactive protein as markers of inflammation.
    Wu TL; I Chen Tsai ; Chang PY; Tsao KC; Sun CF; Wu LL; Wu JT
    Clin Chim Acta; 2007 Feb; 376(1-2):72-6. PubMed ID: 16916504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inflammation, dyslipidemia and vascular risk factors in hemodialysis patients.
    Wanner C; Zimmermann J; Quaschning T; Galle J
    Kidney Int Suppl; 1997 Nov; 62():S53-5. PubMed ID: 9350681
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Atherogenesis and the acute-phase reaction of the liver].
    Nagornev VA; Nazarov PG; Polevshchikov VA; Rabinovich VS; Kositskaia LS; Vasil'eva LE; Pigarevskiĭ PV
    Arkh Patol; 1998; 60(6):62-8. PubMed ID: 9949910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patients with a history of stable or unstable coronary heart disease have different acute phase responses to an inflammatory stimulus.
    Werba JP; Veglia F; Amato M; Baldassarre D; Massironi P; Meroni PL; Riboldi P; Tremoli E; Camera M
    Atherosclerosis; 2008 Feb; 196(2):835-40. PubMed ID: 17335831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Inflammatory markers; C-reactive protein (CRP) and serum amyloid A (SAA)].
    Yamada T
    Rinsho Byori; 2005 Jun; 53(6):558-61. PubMed ID: 16026085
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study.
    Kinlay S; Schwartz GG; Olsson AG; Rifai N; Leslie SJ; Sasiela WJ; Szarek M; Libby P; Ganz P;
    Circulation; 2003 Sep; 108(13):1560-6. PubMed ID: 12975259
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of infection as a risk factor for atherosclerosis, myocardial infarction, and stroke.
    Mattila KJ; Valtonen VV; Nieminen MS; Asikainen S
    Clin Infect Dis; 1998 Mar; 26(3):719-34. PubMed ID: 9524851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-sensitivity C-reactive protein predicts adverse outcomes after non-ST-segment elevation acute coronary syndrome regardless of GRACE risk score, but not after ST-segment elevation myocardial infarction.
    Raposeiras Roubín S; Barreiro Pardal C; Roubín-Camiña F; Ocaranza Sanchez R; Alvarez Castro E; Paradela Dobarro B; García-Acuña JM; Aguiar Souto P; Jacquet Hervet M; Castromán MJ; Arufe I; Outes B; Reino-Maceiras MV; Abu Assi E; González-Juanatey JR
    Rev Port Cardiol; 2013 Feb; 32(2):117-22. PubMed ID: 23337430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inflammation, C-reactive protein, and atherothrombosis.
    Ridker PM; Silvertown JD
    J Periodontol; 2008 Aug; 79(8 Suppl):1544-51. PubMed ID: 18673009
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early increase in levels of soluble inter-cellular adhesion molecule-1 (sICAM-1); potential risk factor for the acute coronary syndromes.
    O'Malley T; Ludlam CA; Riemermsa RA; Fox KA
    Eur Heart J; 2001 Jul; 22(14):1226-34. PubMed ID: 11440495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.
    Ridker PM; Hennekens CH; Buring JE; Rifai N
    N Engl J Med; 2000 Mar; 342(12):836-43. PubMed ID: 10733371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Statin therapy improves cardiovascular outcome of patients with peripheral artery disease.
    Schillinger M; Exner M; Mlekusch W; Amighi J; Sabeti S; Muellner M; Rumpold H; Wagner O; Minar E
    Eur Heart J; 2004 May; 25(9):742-8. PubMed ID: 15120884
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum albumin predicts cardiac adverse events in patients with advanced atherosclerosis - interrelation with traditional cardiovascular risk factors.
    Schillinger M; Exner M; Mlekusch W; Amighi J; Sabeti S; Schlager O; Wagner O; Minar E
    Thromb Haemost; 2004 Mar; 91(3):610-8. PubMed ID: 14983239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inflammatory response in unstable angina.
    Rus H; Niculescu F
    Circulation; 1999 Nov; 100(19):e98. PubMed ID: 10556236
    [No Abstract]   [Full Text] [Related]  

  • 39. [Inflammation, atherosclerosis and acute coronary syndromes].
    Biasucci LM; Santamaria M; Liuzzo G
    Minerva Cardioangiol; 2002 Oct; 50(5):475-86. PubMed ID: 12384630
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-sensitivity C-reactive protein and atherosclerotic disease: from improved risk prediction to risk-guided therapy.
    Koenig W
    Int J Cardiol; 2013 Oct; 168(6):5126-34. PubMed ID: 23978367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.